Concepedia

Publication | Open Access

Idarubicin‐loaded beads for chemoembolisation of hepatocellular carcinoma: results of the<scp>IDASPHERE</scp>phase I trial

DOIFull Paper Access

59

Citations

29

References

2014

Year

Mathieu Boulin, Patrick Hillon, Jean–Pierre Cercueil, Franck Bonnetain, Anne Minello, J L Jouve, Côme Lepage, Marc Bardou, Maëva Wendremaire, Pascal Guérard,
Alimentary Pharmacology & Therapeutics

Abstract

Using drug-eluting beads, the maximum-tolerated dose of idarubicin was 10 mg per TACE session. Encouraging responses and median time to progression were observed. Further clinical investigations are warranted (NCT01040559).

References

YearCitations

Page 1